PFA
SRNE

Pathway Financial Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Pathway Financial Advisers’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30
Closed -$27 – 568
2022
Q4 		$27 Buy
+30
New +$27 ﹤0.01% 558